glp 1 agonist in ckd GLP-1 receptor agonists effects on established and presumed drivers of The potential of GLP-1 receptor
Description
Only individuals with HbA1c 6.5% (or 48 mmol/mol) or a type 2 diabetes diagnosis at any time until cohort entry were included
Lipoprotein (a) is not associated with lifestyle factors but is considered to have additive ASCVD risk to BMI [17]
Feng P, Zhang X, Li D, Ji C, Yuan Z, Wang R, et al
Very convenient and professional
